Glaucoma is a leading cause of irreversible visual impairment and blindness, affecting over
76.0 million people worldwide in 2020, with a predicted increase to 111.8 million by 2040 …

Glaucoma is a leading cause of irreversible blindness worldwide. To date, intraocular
pressure (IOP) is the only modifiable risk factor in glaucoma treatment, but even in treated …

Glaucoma causes irreversible vision loss, with elevated intraocular pressure (IOP) being the
only known modifiable risk factor. There are a variety of medical and interventional options …

Purpose A randomized, double-masked, multicenter, phase 2 trial to evaluate the long-term
safety and efficacy of travoprost intraocular implant, an extended-release drug delivery …

Introduction Glaucoma is a progressive optic neuropathy and the leading cause of
irreversible vision loss. By 2040, the number of individuals with glaucoma is expected to …

Neurodegenerative diseases affecting the visual system encompass glaucoma, macular
degeneration, retinopathies, and inherited genetic disorders such as retinitis pigmentosa …

Cannabidiol (CBD), the major non-intoxicating constituent of Cannabis sativa, has gained
recent attention due to its putative therapeutic uses for a wide variety of diseases. CBD was …

Intraocular pressure (IOP) is regulated primarily through aqueous humor production by
ciliary body and drainage through uveoscleral and trabecular meshwork (TM) tissues. The …

Glaucoma is the primary cause of irreversible blindness worldwide. The current treatments
are primarily based on drug usage or surgical operation to reduce intraocular pressure …

Purpose The impact of various preoperative glaucoma medications on Schlemm's canal
surgery outcomes remains unclear. This study aimed to investigate the impact of …